FUBP3 regulates chronic myeloid leukaemia progression through PRC2 complex regulated PAK1‐ERK signalling
The development of resistance and heterogeneity in differential response towards tyrosine
kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) treatment has led to the …
kinase inhibitors (TKI) in chronic myeloid leukaemia (CML) treatment has led to the …
[HTML][HTML] The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia
Background: Chronic Myeloid Leukemia's (CML) treatment was optimized since the
development of tyrosine kinase inhibitors (TKI) and an increased overall survival during TKI …
development of tyrosine kinase inhibitors (TKI) and an increased overall survival during TKI …
[HTML][HTML] Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy
S Luatti, C Baldazzi, G Marzocchi, G Ameli… - Oncotarget, 2017 - ncbi.nlm.nih.gov
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia
chromosome (Ph), despite the presence of the BCR/ABL rearrangement. Two mechanisms …
chromosome (Ph), despite the presence of the BCR/ABL rearrangement. Two mechanisms …
Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib
A Quintás‐Cardama, H Kantarjian, J Shan, E Jabbour… - Cancer, 2011 - Wiley Online Library
BACKGROUND: Deletions of derivative chromosome 9 are a poor prognostic factor in
patients with chronic myeloid leukemia (CML) treated with hydroxyurea, interferon, or stem …
patients with chronic myeloid leukemia (CML) treated with hydroxyurea, interferon, or stem …
Chronic myeloid leukemia: current perspectives
Y Zhang, JD Rowley - Clinics in laboratory medicine, 2011 - labmed.theclinics.com
Chronic myeloid leukemia (CML) is a rare type of leukemia (1–2 per 100,000 people) but is
the most common chronic myeloproliferative neoplasm with the proliferation of multiple …
the most common chronic myeloproliferative neoplasm with the proliferation of multiple …
Predictive and Prognostic implications of variant Philadelphia translocations in CML: Experience from a tertiary oncology center in Southern India
GB Kanakasetty, L Kuntejowdahalli, AH Thanky… - … Myeloma and Leukemia, 2017 - Elsevier
Introduction Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized
by Philadelphia (Ph) chromosome with classical t (9; 22)(q34; q11) seen in up to 90% of …
by Philadelphia (Ph) chromosome with classical t (9; 22)(q34; q11) seen in up to 90% of …
Molecular characterization and follow‐up of five CML patients with new BCR–ABL 1 fusion transcripts
S Huet, S Dulucq, A Chauveau… - Genes …, 2015 - Wiley Online Library
We report five chronic myeloid leukaemia (CML) patients in whom we identified and
characterized undescribed BCR–ABL1 fusion transcripts. We investigated the precise …
characterized undescribed BCR–ABL1 fusion transcripts. We investigated the precise …
Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
Background: Chronic myelogenous leukemia (CML) is characterised by the t (9; 22)(q34;
q11. 2) which results in the formation of the BCR/ABL1 fusion gene. Occasionally, the t (9; …
q11. 2) which results in the formation of the BCR/ABL1 fusion gene. Occasionally, the t (9; …
Chronic myeloid leukemia
T Fioretos - … and Molecular Genetic Aberrations of Tumor Cells, 2015 - Wiley Online Library
Chronic myeloid leukemia (CML) is a clonal bone marrow (BM) disease characterized by
neoplastic overproduction of, mainly, granulocytes. The treatment of CML has changed …
neoplastic overproduction of, mainly, granulocytes. The treatment of CML has changed …
Update on current monitoring recommendations in chronic myeloid leukemia: practical points for clinical practice
VG Oehler - Hematology 2013, the American Society of …, 2013 - ashpublications.org
Excellent therapeutic options exist for the treatment of chronic-phase chronic myeloid
leukemia (CML) patients. Therefore, managing CML patients has become a more common …
leukemia (CML) patients. Therefore, managing CML patients has become a more common …